Current and Recent Projects
- On June 23, 2014, CONRAD, AVAC and the Forum for Collaborative HIV Research convened a workshop on alternative trial designs for microbicides which generated lively discussion among more than 60 participants. A number of possible designs were presented, as described in the attached proceedings.
The 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care will be held on June 4-6, 2015 in Arlington, VA.
Non-alcoholic fatty liver disease (NAFLD), chronic hepatitis B (HBV), and chronic hepatitis C infection are the leading causes of chronic liver disease and hepatocellular carcinoma in the US. NAFLD, comprising non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) affects 30% of the adult population and at least 10% of children. NASH related liver transplantations are predicted to eclipse other indications over the next decade, and NASH has emerged as the dominant cause of hepatocellular carcinoma (HCC), the only cancer with rising incidence and third leading cause of cancer mortality.